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ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to consider evaluations of flavouring substances assessed since 2000 by the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide whether further evaluation is 
necessary, as laid down in Commission Regulation (EC) No 1565/2000. The present consideration concerns a 
group of 20 aliphatic secondary alcohols, ketones and related esters evaluated by the JECFA at the 59
th and 69
th 
meetings in 2002 and 2008. This revision is made due to inclusion of one additional substance, 4-methylpent-3-
en-2-one [FL-no: 07.101], cleared for genotoxicity concern. The substances were evaluated through a stepwise 
approach that integrates information on structure-activity relationships, intake from current uses, toxicological 
threshold of concern, and available data on metabolism and toxicity. The Panel agrees with the application of the 
Procedure as performed by the JECFA for all 20 substances considered in this FGE and agrees with the JECFA 
conclusion, “No safety concern at estimated levels of intake as flavouring substances” based on the MSDI 
approach. Besides the safety assessment of these flavouring substances, the specifications for the materials of 
commerce have also been considered and for all 20 substances, the information is adequate. 
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SUMMARY 
Following a request from the European Commission the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (CEF Panel) was asked to deliver a scientific opinion to provide 
scientific advice to the Commission on the implications for human health of chemically defined 
flavouring substances used in or on foodstuffs in the Member States. In particular, the Panel was 
requested to consider the Joint FAO/WHO Expert  Committee on Food Additives (the JECFA) 
evaluations of flavouring substances assessed since 2000, and to decide whether no further evaluation 
is necessary, as laid down in Commission Regulation (EC) No 1565/2000. These flavouring 
substances are listed in the Register, which was adopted by Commission Decision 1999/217/EC and 
its consecutive amendments. 
In Flavouring Group Evaluation 63, Revision 1 (FGE.63Rev1) the EFSA considered 19 flavouring 
substances from two groups of flavouring substances consisting of aliphatic secondary alcohols, 
ketones and related esters evaluated by the JECFA at its 59
th meeting and at its 69
th meeting. The 
present revision of FGE.63, FGE.63Rev2, includes the consideration of one additional substance, 4-
methylpent-3-en-2-one [FL-no: 07.101]. This substance [FL-no: 07.101] was evaluated by the JECFA 
at its 59
th meeting and the substance is an α,β-unsaturated ketone originally allocated to and evaluated 
in FGE.204 in which it was considered not to be of concern with respect to genotoxicity. The Panel 
concluded that the additional substance fits well together with the 19 aliphatic secondary alcohols, 
ketones and related esters considered in the FGE.63.Rev1. Therefore, the present revision of FGE.63, 
FGE.63Rev2, considers 20 flavouring substances evaluated by the JECFA. 
The Panel concluded that the 20 substances in the JECFA flavouring group of aliphatic secondary 
alcohols, ketones and related esters are structurally related to the group of 49 saturated and 
unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated 
linear or branched-chain carboxylic acids evaluated in FGE.07Rev4. 
The Panel agrees with the application of the Procedure as performed by the JECFA for the 20 
substances considered in this FGE.  
For all 20  substances,  the JECFA evaluation is based on MSDI values derived from production 
figures from the EU. 
For three substances [FL-no: 02.252, 07.190 and 09.936], the Industry has submitted normal and 
maximum use levels. For [FL-no: 02.252 and 09.936],  which are expected to be metabolised to 
innocuous products, the mTAMDI values are below their respective thresholds of concern for 
structural class I (1800 microgram/person/day) and class II (540 microgram/person/day). For 
substance [FL-no: 07.190], the mTAMDI value is above the threshold of concern for structural class 
II of 540 microgram/person/day to which it is allocated. Therefore, for this substance more reliable 
exposure data are required. On the basis of such additional data, the flavouring substance should be 
reconsidered along the steps of the Procedure. Following this procedure additional toxicological data 
might become necessary. For the remaining 17 substances evaluated through the Procedure, use levels 
are needed to calculate the mTAMDIs in order to identify those flavouring substances that need more 
refined exposure assessment in order to finalise the evaluation. 
In order to determine whether the conclusion for the 20 JECFA-evaluated substances can be applied 
to the materials of commerce, it is necessary to consider the available specifications.  Adequate 
specifications including complete purity criteria and identity are available for all 20 JECFA-evaluated 
substances.  
Thus, for all 20 JECFA evaluated aliphatic secondary alcohols, ketones and related esters [FL-no: 
02.252,  07.015, 07.069, 07.099,  07.100,  07.101,  07.114,  07.123, 07.151, 07.190, 07.240, 07.247, Flavouring Group Evaluation 63, Revision 2 
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07.249, 07.256, 09.657, 09.658, 09.923, 09.924, 09.925 and 09.936] the Panel agrees with the JECFA 
conclusion “No safety concern at estimated levels of intake as flavouring substances” based on the 
MSDI approach. Flavouring Group Evaluation 63, Revision 2 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Regulation (EC) No 2232/96
4 of the European Parliament and the Council lays down a Procedure for 
the establishment of a list of flavouring substances, the use  of which will be authorised to the 
exclusion of all other substances in the EU. In application of that Regulation, a Register of flavouring 
substances used in or on foodstuffs in the Member States was adopted by Commission Decision 
1999/217/EC
5, as last amended by Commission Decision 2009/163/EC
6
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000
. Each flavouring substance is 
attributed a FLAVIS-number (FL-number) and all substances are divided into 34 chemical groups. 
Substances within a group should have some metabolic and biological behaviour in common. 
7
Commission  Regulation (EC) No 1565/2000 lays down that substances that are contained in the 
Register and will be classified in the future by the Joint FAO/WHO Expert Committee on Food 
Additives (the JECFA) so as to present no safety concern at current levels of intake will be considered 
by the European Food Safety Authority (EFSA), who may then decide that no further evaluation is 
necessary. 
, which is broadly based on the opinion of 
the Scientific Committee on Food (SCF, 1999).  
In the period 2000 - 2008, during its 55
th, 57
th, 59
th, 61
st, 63
rd, 65
th, 68
th and 69
th meetings, the JECFA 
evaluated about 1000 substances, which are in the EU Register. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The European Food Safety Authority (EFSA) is requested to consider the Joint FAO/WHO Expert 
Committee on Food Additives (the JECFA) evaluations of flavouring substances assessed since 2000, 
and to decide whether no further evaluation is necessary, as laid down in Commission Regulation 
(EC) No 1565/2000. These flavouring substances are listed in the Register, which was adopted by 
Commission Decision 1999/217/EC and its consecutive amendments. The evaluation programme was 
finalised at the end of 2009. 
In addition, the European Commission requests the European Food Safety Authority to carry out a 
safety assessment on the substance  4-methylpent-3-en-2-one [FL-no: 07.101], in accordance with 
Commission Regulation (EC) No 1565/2000. 
                                                       
4  Regulation No 2232/96 of the European Parliament and of the Council of 28 October 1996. Official Journal of the 
European Communities 23.11.1996, L 299, 1-4. 
5  Commission Decision 1999/217/EC of 23 February 1999 adopting a register of flavouring substances used in or on 
foodstuffs. Official Journal of the European Communities 27.3.1999, L 84, 1-137. 
6 Commission Decision 2009/163/EC of 26 February 2009 amending Decision 1999/217/EC as regards the Register of 
flavouring substances used in or on foodstuffs. Official Journal of the European Union 27.2.2009, L 55, 41. 
7  Commission Regulation No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an 
evaluation programme in application of Regulation (EC) No 2232/96. Official Journal of the European Communities 
19.7.2000, L 180, 8-16. Flavouring Group Evaluation 63, Revision 2 
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ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000, hereafter named the “EFSA Procedure”. This Procedure 
is based on the opinion of the Scientific Committee on Food (SCF, 1999), which has been derived 
from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA, 1995; JECFA, 1996; JECFA, 1997; JECFA, 1999), hereafter named the “JECFA 
Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be put through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
In its evaluation, the Panel as a default uses the “Maximised Survey-derived Daily Intake” (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA, at its 65
th meeting 
considered ”how to improve the identification and assessment of flavouring agents, for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided also to perform an estimate 
of the daily intakes per person using a modified “Theoretical Added Maximum Daily Intake” 
(mTAMDI) approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram/person/day as part of the evaluation 
procedure: Flavouring Group Evaluation 63, Revision 2 
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“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 microgram per 
person per day would not be expected to present a safety concern. The Committee recommended that 
the Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be 
amended to include the last step on the right-hand side of the original Procedure (“Do the condition of 
use result in an intake greater than 1.5 microgram per day?”)” (JECFA, 1999).  
In line with the opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 microgram per person per day. 
Genotoxicity 
As reflected in the opinion of SCF (SCF, 1999), the Panel has in its evaluation focussed on a possible 
genotoxic potential of the flavouring substances or of structurally related substances. Generally, 
substances for which the Panel has concluded that there is an indication of genotoxic potential in 
vitro, will not be evaluated using the EFSA Procedure until further genotoxicity data are provided. 
Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated through 
the Procedure. 
Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of the 
JECFA, since the Panel requests information on e.g. isomerism. 
Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
1.  History of the Evaluation of the Substances in the present FGE 
At its 59
st meeting the JECFA evaluated a group of 39 flavouring substances consisting of aliphatic 
secondary alcohols, ketones and related esters  (JECFA, 2003).  One of the JECFA evaluated 
substances is not in the Register [(E,R)-3,7-dimethyl-1,5,7-octatrien-3-ol (JECFA No: 1154)], and 25 
substances [FL-no: 02.023, 02.099, 02.102, 02.104, 02.136, 02.193, 07.044, 07.048, 07.081, 07.082, 
07.099, 07.101, 07.102, 07.104, 07.105, 07.106, 07.107, 07.121, 07.138, 07.139, 07.177, 07.188, 
07.244, 07.247 and 07.256] are α,β-unsaturated ketones or precursors for such, which have been 
considered together with other α,β-unsaturated substances.  FGE.63  therefore only dealt  with 13 
JECFA evaluated substances (EFSA, 2008a). 
The Revision 1 of FGE.63, FGE.63Rev1  (EFSA  Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (CEF), 2012c), included the consideration of six additional 
substances, three substances [FL-no: 07.099, 07.247 and 07.256] were evaluated by the JECFA at 
their 59
th meeting (JECFA, 2003) and three [FL-no: 02.252, 07.190 and 09.936] were evaluated at the 
69
th  meeting  (JECFA, 2009b).  Furthermore, the Industry had  for six substances [FL-no: 07.069, 
07.114, 09.657, 09.658, 09.923 and 09.925] submitted information on the stereoisomeric composition 
and for three  substances  [FL-no: 07.069, 07.100 and 09.658] provided EU production volumes 
(EFFA, 2010). 
 Flavouring Group Evaluation 63, Revision 2 
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FGE  Opinion adopted by 
EFSA 
Link  No. of candidate 
substances 
63  7 July 2007  http://www.efsa.europa.eu/en/efsajournal/pub/706.htm  13 
63Rev1  26 September 2012  http://www.efsa.europa.eu/en/efsajournal/pub/2900.htm   19 
63Rev2  9 April 2013    20 
 
The present revision of FGE.63, FGE.63Rev2, includes the consideration of one additional substance, 
4-methylpent-3-en-2-one  [FL-no: 07.101]. This  substance is an  α,β-unsaturated ketone  and was 
originally evaluated in FGE.204 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF), 2012d) in which it was considered not to be of concern with respect to 
genotoxicity. 
2.  Presentation of the Substances in the JECFA Flavouring Group 
2.1.  Description 
2.1.1.  JECFA Status 
This FGE deals with 20 JECFA evaluated substances, seventeen substances from the 59
th meeting, 
2002, and three substances from the 69
th meeting, 2008: 
•  Of the 39 aliphatic secondary alcohols, ketones and related esters evaluated by the JECFA at 
the 59
th meeting (JECFA, 2003) one is not in the Register [(E,R)-3,7-dimethyl-1,5,7-octatrien-
3-ol (JECFA No: 1154)], and 25 substances [FL-no: 02.023, 02.099, 02.102, 02.104, 02.136, 
02.193, 07.044, 07.048, 07.081, 07.082, 07.099, 07.101, 07.102, 07.104, 07.105, 07.106, 
07.107, 07.121, 07.138, 07.139, 07.177, 07.188, 07.244,  07.247  and 07.256] are α,β-
unsaturated ketones or precursors for such, which have been considered together with other 
α,β-unsaturated substances. Of these 25 substances, three substances [FL-no: 07.099, 07.247 
and 07.256] were evaluated in FGE.206 (EFSA Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (CEF), 2011) in which they were considered not to be of 
concern with respect to genotoxicity. These three substances were included in revision 1 of 
FGE.63, FGE.63Rev1. Another one of these 25 substances, 4-methylpent-3-en-2-one [FL-no: 
07.101],  was evaluated in FGE.204 (EFSA  Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (CEF), 2012d) in which the substance was considered not to 
be of concern with respect to genotoxicity.  Therefore,  from the 59
th  JECFA meeting,  17 
substances are considered in this FGE.63Rev2. 
•  Of the 17 aliphatic secondary alcohols, ketones and related esters evaluated by the JECFA at 
the 69
th meeting (JECFA, 2009b) five are not in the Register [(E,Z)-4-octen-3-one (JECFA 
No: 1843), (E)-2-nonen-4-one (JECFA No: 1844), (E)-5-nonen-2-one (JECFA No: 1845), 10-
undecen-2-one (JECFA No: 1849) and 8-nonen-2-one (JECFA No: 1851)], six have been 
evaluated in other FGEs to be of no safety concern [FL-no: 02.253, 07.097, 07.239, 09.565, 
09.822 and 09.938], and three substances [FL-no: 02.155, 09.281 and 09.282] have been 
evaluated in FGE.205 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF), 2012b) in which they were considered to be of concern with respect 
to genotoxicity. The remaining three substances [FL-no: 02.252, 07.190 and 09.936] were 
evaluated in FGE.206 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF),  2011)  in which they were considered not to be of concern with 
respect to genotoxicity. These three substances were  included in revision  1  of FGE.63, 
FGE.63Rev1 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing 
Aids (CEF), 2012c). Flavouring Group Evaluation 63, Revision 2 
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2.1.2.  EFSA Considerations 
Seven of the α,β-unsaturated ketones [FL-no: 02.252, 07.099, 07.101, 07.190, 07.247, 07.256 and 
09.936] evaluated by the JECFA at its 59
th and 69
th meetings (JECFA, 2003; JECFA, 2009b) were 
evaluated by EFSA  with respect to genotoxicity, six  in FGE.206 (EFSA Panel on Food Contact 
Materials, Enzymes, Flavourings and Processing Aids (CEF), 2011) and one in FGE.204 (EFSA Panel 
on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 2012d)  and were 
considered not to be of concern with respect to genotoxicity. 
The Panel concluded that these  seven  substances together with 13  aliphatic secondary alcohols, 
ketones and related esters considered in FGE.63 are structurally related to the group of 49 saturated 
and unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated 
linear or branched-chain carboxylic acids evaluated by EFSA in Flavouring Group Evaluation 07, 
Revision 4 (FGE.07Rev4)  (EFSA  Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF), 2012a). 
2.2.  Isomers 
2.2.1.  Status 
Eight substances in the group of JECFA evaluated aliphatic secondary alcohols, ketones and related 
esters have a chiral centre [FL-no:  02.252,  07.069, 09.657, 09.658, 09.923, 09.924,  09.925  and 
09.936] and eight  substances can exist as geometrical isomers [FL-no:  02.252, 07.099, 07.114, 
07.123, 07.190, 07.247, 07.256 and 09.936]. 
2.2.2.  EFSA Considerations 
Adequate information on isomeric composition is available for all substances. It is foreseen that no 
quantitative information on the stereoisomeric composition of [FL-no: 07.114] can be obtained. 
Therefore, the Panel consider the available information adequate. 
For the substance [FL-no: 07.123], the CAS register number (CASrn) specify the stereoisomeric 
composition. 
2.3.  Specifications 
2.3.1.  JECFA Status 
The JECFA specifications are available for all 20 substances (JECFA, 2002b; JECFA, 2009a). See 
Table 3. 
2.3.2.  EFSA Considerations 
No comments. 
3.  Intake Estimations 
3.1.  JECFA Status 
For all 20 substances evaluated by the JECFA, intake data (MSDI) were available for the EU, see 
Table 2 and Table 9.  Flavouring Group Evaluation 63, Revision 2 
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3.2.  EFSA Considerations 
For all substances the Industry has submitted production figure for EU.  
For three substances [FL-no: 02.252, 07.190 and 09.936], the Industry has submitted use levels for 
normal and maximum use (Flavour Industry, 2004) (see Table 1). Based on these normal use levels, 
mTAMDI values can be calculated (see Table 2), (EFSA, 2004). For one substance [FL-no: 07.190], 
the mTAMDI value  is above the thresholds of concern for structural class II  of 540 
microgram/person/day  to which it is allocated.  The remaining two flavouring substances [FL-no: 
02.252 and 09.936] have mTAMDI intake estimates below the threshold of concern for their 
structural class (class I and class II, respectively). 
For 17 substances, use levels are needed in order to calculate the mTAMDIs. 
Table 1:   Normal and Maximum use levels (mg/kg) available for three JECFA evaluated substances in 
FGE.63Rev2 
FL-no  Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0  02.0  03.0  04.1  04.2  05.0  06.0  07.0  08.0  09.0  10.0  11.0  12.0  13.0  14.1  14.2  15.0  16.0 
02.252  0,0005 
0,025 
0,0005 
0,025 
0,005 
0,25 
0,0005 
0,025 
0,0005 
0,025 
0,05 
2,5 
- 
- 
0,005 
0,25 
0,0005 
0,025 
0,0005 
0,025 
- 
- 
- 
- 
0,0005 
0,025 
- 
- 
0,05 
2,5 
0,05 
2,5 
0,0005 
0,025 
0,0005 
0,025 
07.190  3 
15 
2 
10 
3 
15 
2 
10 
- 
- 
4 
20 
2 
10 
5 
25 
1 
5 
1 
5 
- 
- 
- 
- 
2 
10 
3 
15 
2 
10 
4 
20 
5 
25 
2 
10 
09.936  0,0005 
0,025 
0,0005 
0,025 
0,005 
0,25 
0,0005 
0,025 
0,0005 
0,025 
0,05 
2,5 
- 
- 
0,005 
0,25 
0,0005 
0,025 
0,0005 
0,025 
- 
- 
- 
- 
0,0005 
0,025 
- 
- 
0,05 
2,5 
0,05 
2,5 
0,0005 
0,025 
0,0005 
0,025 
 
Table 2:   Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no  EU Register name  MSDI – EU 
(µg/capita/day) 
MSDI – USA 
(µg/capita/day) 
mTAMDI 
(µg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
02.252  4,8-Dimethyl-3,7-nonadien-2-ol  3  0.1  19  Class I  1800 
09.657  1-Methylbutyl acetate  2.9  3    Class I  1800 
09.658  1-Methylbutyl butyrate  0.47  1    Class I  1800 
09.923  Hept-2-yl butyrate  3.0  3    Class I  1800 
09.924  (+/-)-3-Heptyl acetate  3.0  3    Class I  1800 
09.925  Nonan-3-yl acetate  3.0  3    Class I  1800 
07.015  6-Methylhept-5-en-2-one  100  44    Class II  540 
07.069  Tetrahydro-pseudo-ionone  0.012  0.01    Class II  540 
07.099  6-Methylhepta-3,5-dien-2-one  13  5    Class II  540 
07.100  5-Methylhex-5-en-2-one  0.24  0.3    Class II  540 
07.101  4-Methylpent-3-en-2-one  0.34  ND    Class II  540 
07.114  6,10,14-Trimethylpentadeca-5,9,13-
trien-2-one 
0.085  ND    Class II  540 
07.123  Geranylacetone  41  2    Class II  540 
07.151  Decan-3-one  3.0  3    Class II  540 
07.190  Octa-1,5-dien-3-one  0.061  ND  1600  Class II  540 
07.240  2-Methylheptan-3-one  3.0  3    Class II  540 
07.247  (E,E)-3,5-Octadien-2-one  3.0  4    Class II  540 
07.249  Undecan-6-one  3.0  3    Class II  540 
07.256  (3Z)-4,8-Dimethyl-3,7-nonadiene-2-
one 
6.1  6.6    Class II  540 
09.936  4,8-Dimethyl-3,7-nonadien-2-yl acetate  3  0.2  19  Class II  540 
ND – not determined Flavouring Group Evaluation 63, Revision 2 
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4.  Genotoxicity Data 
4.1.  Genotoxicity Studies  
4.1.1.  Genotoxicity Studies - Text taken
8
In vitro  
 from the 59
th JECFA meeting (JECFA, 2003) 
Assays for reverse mutation were performed with 6-methyl-5-hepten-2-one [FL-no: 07.015] and 6-
methyl-3,5-heptadien-2-one [FL-no: 07.099]. There was no evidence of mutagenicity for 6-methyl-5-
hepten-2-one at concentrations up to 380 µg/plate in TA98, TA100, TA1535 or TA1537 strains of 
Salmonella typhimurium (Florin et al., 1980). There was also no evidence of mutagenicity for 6-
methyl-3,5-heptadien-2-one at concentrations up to 370 µg/plate in the same strains (Florin et al., 
1980). 
In vivo 
No in vivo studies were reported by the JECFA at the 59
th meeting. 
For a summary of in vitro / in vivo genotoxicity data considered by the JECFA, see Table 4. 
4.1.2.  Genotoxicity Studies - Text taken
9
For the substances evaluated by the JECFA at the 69
th meeting, no genotoxicity data were provided 
(JECFA, 2009b). 
 from the 69
th JECFA meeting (JECFA, 2009b) 
4.2.  Genotoxicity Studies - Text taken
10
In vitro / In vivo  
 from EFSA FGE.07Rev4 (EFSA Panel on Food 
Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 2012a) 
In vitro genotoxicity data have been reported for nine candidate substances. Negative results were 
obtained in bacterial systems (+/- metabolic activation) with six candidate substances: one saturated 
aliphatic acyclic secondary alcohol [FL-no: 02.183]; two saturated ketones [FL-no: 07.181 and 
07.205]; two unsaturated ketones [FL-no: 07.198 and 07.262] and the ester isopropyl hexadecanoate 
[FL-no: 09.606]. Negative results were also obtained for the candidate substances pseudo-ionone [FL-
no: 07.198], pentan-3-ol [FL-no: 02.077] and methyl-3-butan-2-one [FL-no: 07.178], the two first 
mentioned being tested for chromosomal aberrations in mammalian cells and the latter for induction 
of aneuploidy in yeast cells, respectively.  
Induction of aneuploidy in yeast cells has been demonstrated for pentan-3-one [FL-no: 07.084]. The 
effect, measured only at high concentrations, approaching cytotoxic levels, can be considered to be a 
threshold effect, not mediated by direct interaction with DNA. In addition, induction of aneuploidy 
described in the paper is strongly potentiated by ice treatments included in the experimental protocol, 
consistently with tubulin dissociation at low temperature in vitro; in the absence of this passage the 
effect is very weak. Therefore, the effect could be considered as an effect occurring only under 
unrealistic experimental conditions and the extrapolation of this result to the in vivo situation in 
                                                       
8 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed. 
9 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed. 
10 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed. Flavouring Group Evaluation 63, Revision 2 
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humans is questionable. Furthermore, it is well recognised that the relevance of fungal systems is 
limited when induction of aneuploidy in mammalian systems has to be evaluated. 
Pseudo-ionone [FL-no: 07.198] was considered with respect to genotoxicity in FGE.206 (EFSA Panel 
on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 2011) where the Panel 
concluded that the data available ruled out the concern for genotoxicity. Pseudo-ionone was tested in 
Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 and TA102 in the presence or 
absence of S9  and it is concluded that under the test conditions applied pseudo-ionone  is not 
mutagenic in bacteria. Pseudo-ionone was also evaluated in an in vitro micronucleus assay in human 
peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in the 
presence and absence of rat S9 fraction as an in vitro metabolising system. Under the conditions of 
this study, pseudo-ionone was not clastogenic and/or aneugenic in cultured human lymphocytes. 
In vitro genotoxicity data are also available for 10 supporting substances.  
No evidence of mutagenicity obtained with bacterial and/or mammalian cells systems was reported 
for: one saturated aliphatic acyclic secondary alcohol [FL-no: 02.079], five saturated [FL-no: 07.002, 
07.050, 07.017, 07.053 and 07.122] and two unsaturated [FL-no: 07.015 and 07.099] aliphatic acyclic 
ketones; two esters of an aliphatic acyclic secondary alcohol with linear aliphatic carboxylic acids 
[FL-no: 09.003 and 09.105]. 4-Methyl-2-pentanone [FL-no: 07.017] gave negative results also when 
tested for chromosomal aberration activity. 
Beside the negative results in in vitro bacterial point mutation tests, acetone [FL-no: 07.050] showed 
no evidence of increased sister chromatid exchanges in several cytogenetic assays on different 
mammalian cells, as well as no induction of chromosomal aberrations in Chinese hamster ovary cells 
up to very high concentrations. Only one test on hamster lung fibroblasts (conducted at an unspecified 
acetone concentration) and an aneuploidy induction test on Saccharomyces cerevisiae (about 7 % 
acetone) gave positive results. However, these two studies were considered not relevant on the basis 
of their poor quality and taking into account all the other negative genotoxicity results obtained with 
acetone, including results in vivo (see below).  
6-Methylhepta-3,5-dien-2-one  [FL-no: 07.099] was  considered with respect to genotoxicity in 
FGE.206 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 
2011) where the Panel concluded that the data available ruled out the concern for genotoxicity. 6-
Methylhepta-3,5-dien-2-one was tested in Salmonella typhimurium strains TA98, TA100, TA1535, 
TA1537 and TA102 in the presence or absence of S9  and it was  concluded that under the test 
conditions applied 6-methylhepta-3,5-dien-2-one  is not mutagenic in bacteria.  6-Methylhepta-3,5-
dien-2-one  was  also  evaluated in an in vitro micronucleus assay in human peripheral blood 
lymphocytes for its ability to induce chromosomal damage or aneuploidy in the presence and absence 
of rat S9 fraction as an in vitro metabolising system. Under the conditions of this study,  6-
methylhepta-3,5-dien-2-one was not clastogenic and/aneugenic in cultured human lymphocytes. 
In vivo data are available for four supporting substances: one saturated aliphatic secondary alcohol 
[FL-no: 02.079] and three saturated aliphatic ketones [FL-no: 07.017, 07.050 and 07.053], which 
exhibited no genotoxic potential in the micronucleus cytogenetic assay at doses approaching the LD20 
and the LD50 of the tested substances.  
Conclusion on Genotoxicity 
On the basis of available data from in vitro and in vivo tests on candidate and supporting substances, 
it can be concluded that the 49 candidate substances included in this group exhibit no genotoxic 
potential. 
For a summary of in vitro / in vivo genotoxicity data considered by EFSA, see Table 5 and 6. Flavouring Group Evaluation 63, Revision 2 
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4.3.  Genotoxicity Studies -  Text  taken
11
The Industry has submitted data concerning genotoxicity studies for 6-methylhepta-3,5-dien-2-one 
[FL-no: 07.099], a representative substance for FGE.19, subgroup 1.2.3 (EFSA, 2008b), evaluated in 
FGE.206 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 
2011).  In this revision of FGE.63,  the data below are of importance for the assessment of the 
genotoxic potential of six candidate substances [FL-no: 02.252, 07.099, 07.190, 07.247, 07.256 and 
09.936], which have a structural alert for genotoxicity. 
  from  EFSA FGE.206 (EFSA Panel on Food 
Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 2011) 
In vitro  
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] was tested in Salmonella typhimurium strains TA98, 
TA100, TA1535, TA1537 and TA102 in the presence or absence of S9. In the first experiment the 
concentrations tested were 1.6, 8, 40, 200, 1000 and 5000 μg/plate, and the  plate incorporation 
methodology was used. Severe toxicity was observed at 5000 μg/plate in all strains (complete killing 
of bacteria). No increase in revertant colonies was observed at any of the tested concentrations. In the 
second experiment the concentrations were 20.5, 51.2, 128, 320, 800, 2000 and 5000 μg/plate of 6-
methylhepta-3,5-dien-2-one, and treatments in the presence of S9 were carried out according to the 
pre-incubation method. In the absence of S9 the standard plate incorporation method was performed. 
Slight thinning of the bacterial lawn or complete killing of the bacteria was observed in all strains at 
2000 and 5000 μg/plate in the absence of S9. In the presence of S9, cytotoxicity was observed at 800 
μg/plate and above and severe toxicity (complete killing of bacteria) was observed at 5000 μg/plate in 
all strains (Williams, 2009a). The study design complied with current recommendations (OECD 471; 
GLP) and an acceptable top concentration was achieved. There was no evidence of mutagenic effect 
induced by 6-methylhepta-3,5-dien-2-one in any of the strains, either in the absence or presence of S9. 
No precipitation was observed at any tested concentrations (Williams, 2009a). It is concluded that 
under the test conditions applied, 6-methylhepta-3,5-dien-2-one [FL-no: 07.099] is not mutagenic in 
bacteria. 
6-Methylhepta-3,5-dien-2-one [FL-no: 07.099] was evaluated in an in vitro micronucleus assay in 
human peripheral blood lymphocytes for its ability to induce chromosomal damage or aneuploidy in 
the presence and absence of rat S9 fraction as an in vitro metabolising system. The assay was 
performed in accordance with OECD 487 Guideline and in compliance with GLP. In a preliminary 
toxicity study, a wide range of concentrations up to 2000 μg/ml of 6-methylhepta-3,5-dien-2-one was 
tested. The highest concentration used in the main test (450 μg/ml) was limited by toxicity observed 
in the preliminary study. Cells were stimulated for 48 hours with phytohaemaglutinin to produce 
exponentially growing cells, and then treated for 3 hours (followed by 21 hours recovery) with 0, 225, 
325 or 450 μg/ml of 6-methylhepta-3,5-dien-2-one in the absence of S9 and 0, 225, 300 and 350 μg/ml 
in the presence of S9, respectively. The levels of toxicity (reduction in replication index) at the top 
concentrations were 60 % and 51 % without and with S9, respectively. In a parallel assay, cells were 
treated for 24 hours with 0, 100, 120 or 150 μg/ml of 6-methylhepta-3,5-dien-2-one in the absence of 
S9 with no recovery period. The top concentration induced 56 % toxicity. There were 2 replicate 
cultures per treatment, and 1000 binucleate cells per replicate (i.e. 2000 cells per dose) were scored 
for micronuclei. No evidence of chromosomal damage or aneuploidy was observed  by increased 
levels of micronucleated binucleate cells (MNBN) in the presence or absence of S9 metabolic 
activation (Whitwell, 2010). Under the conditions of this study, 6-methylhepta-3,5-dien-2-one was not 
clastogenic and/aneugenic in cultured human lymphocytes. 
For a summary of in vitro genotoxicity data considered by EFSA, see Table 7. 
 
                                                       
11 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed. Flavouring Group Evaluation 63, Revision 2 
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Conclusion on Genotoxicity 
The Panel concluded that the  in vitro  genotoxicity data on 6-methylhepta-3,5-dien-2-one  [FL-no: 
07.099] do not indicate genotoxic potential. 
4.4.  Genotoxicity Studies -  Text  taken
12
The Industry has submitted data concerning genotoxicity studies for 4-methylpent-3-en-2-one [FL-no: 
07.101], a substance from FGE.19, subgroup 1.2.1 (EFSA, 2008b), evaluated in FGE.204 (EFSA 
Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 2012d). In this 
revision of FGE.63, the data below are of importance for the assessment of the genotoxic potential of 
the candidate substance [FL-no: 07.101], which have a structural alert for genotoxicity. 
  from  EFSA FGE.204 (EFSA  Panel on Food 
Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 2012d) 
In vitro  
Bacterial Reverse Mutation Assay 
An Ames assay was conducted in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 
and TA102 to assess the mutagenicity of 4-methylpent-3-en-2-one  [FL-no: 07.101], both in the 
absence and presence of rat liver metabolising system (S9-mix) in two experiments (Williams, 
2009b). A preliminary range-finding cytotoxicity experiment using standard plate-incorporation 
methodology was conducted in strain TA100 only at concentrations of 1.6, 8, 40, 200, 1000 and 5000 
μg/plate  in  the  absence  and  presence  of  S9-mix, plus negative (solvent) and positive controls. 
Evidence of toxicity, in terms of a slight thinning of the background bacterial lawn, was observed 
only at the top concentration in the presence of S9-mix. The data from the range-finding experiment 
were considered acceptable for mutation assessment, and therefore, to complete the first experiment, 
the remaining four strains were tested at the same concentrations both in the presence and absence of 
S9-mix using the same methodology. No evidence of toxicity was observed in these strains, and no 
increases in reverse mutants relative to the vehicle control were observed. 
In a second experiment, 4-methylpent-3-en-2-one was tested in all five S. typhimurium strains with 
and without S9-mix using a narrowed concentration range of 156.25, 312.5, 625, 1250, 2500 and 5000 
μg/plate. A pre-incubation step was also included when the chemical was tested in the presence of S9-
mix. Following these treatments, evidence of toxicity in the form of a slight thinning of the 
background bacterial lawn was observed at the highest concentrations (2500 and 5000 μg/plate) in all 
strains in the presence of S9-mix and in strain TA102 in the absence of S9-mix. A small increase (1.5-
fold) in TA1535 revertants was seen at the higest concentration in the absence of S9-mix that was 
significant at p < 0.05, but this small increase was not seen in the first experiment at similar 
concentrations and was considered by the study authors to be due to chance. No increases in revertant 
numbers were observed for the other strains and treatment conditions. 
Based on the above results the Panel concluded that 4-methylpent-3-en-2-one [FL-no: 07.101] did not 
induce mutations in five strains of S. typhimurium when tested up to toxic concentrations in the 
absence and in the presence of metabolic activation (Williams, 2009b). 
In vitro micronucleus assay 
4-Methylpent-3-en-2-one [FL-no: 07.101] was tested for the induction of chromosome damage and 
potential aneugenic effects in mammalian cells in vitro by examining the effect on the frequency of 
                                                       
12 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present 
FGE has been removed. Flavouring Group Evaluation 63, Revision 2 
 
EFSA Journal 2013;11(4):3188  17 
micronuclei in cultured human peripheral blood lymphocytes, treated in the absence and presence of 
rat liver metabolising system (S9-mix) (Stone, 2011). 
A preliminary range-finding experiment was conducted with and without S9-mix, in order to 
determine the effect of the test substance upon Replication Index (RI), which was used as a basis for 
choosing a range of concentrations to be evaluated in the main study. 4-Methylpent-3-en-2-one was 
added to cell cultures after 48 hours from culture initiation (stimulation by phytohaemagglutinin 
PHA), either for 3 hours in the absence or presence of S9-mix, or for 24 hours in the absence of S9-
mix. Micronuclei were analysed at multiple concentrations for each treatment group. For the 3-hour 
treatment (3 + 21 hours recovery) the concentrations were 0, 600, 800 and 981.4 μg/ml (without S9-
mix) and 0, 200, 400, 800, 981.4 μg/ml (with S9-mix). The levels of cytotoxicity (reduction in RI) 
induced at the top concentrations were 22 % and 54 % in the absence and presence of S9-mix, 
respectively. Although, the recommended range of toxicity (50 - 60 %) was not reached in the absence 
of S9-mix, the top concentration of 981.4 μg/ml was equivalent to 10 mM, which is the required upper 
limit for a non-toxic substance. For 24-hour treatment without S9-mix the concentrations were 0, 100, 
200,  275  and  300  μg/ml  and  the  level  of  cytotoxicity  (reduction  in  RI)  at  the  top  concentration 
reached 62 %, which exceeded the target (50 - 60 %) range. One thousand binucleate cells per culture 
from two replicate cultures per concentration were scored for micronuclei.  
Treatment of cells with 4-methylpent-3-en-2-one for 3 hours in the presence of S9-mix resulted in 
statistically significant (p  ≤ 0.05) increases in MNBN frequency compared to the concurrent vehicle 
control at the highest concentration analysed (981.4 μg/mL). However, only one replicate culture in 
the assay resulted in MNBN cell frequencies outside of the normal range and the authors considered 
this result as equivocal. Therefore a confirmatory experiment was performed with 4-methylpent-3-en-
2-one  at  concentrations  of  0,  100,  200,  400 and 500 μg/ml for 3 hours with S9-mix. The lower 
concentrations chosen in the second experiment were on the basis of an unexplained shift in toxicity, 
but the concentrations selected for analysis in this experiment gave comparable toxicity to those 
selected in the prior experiment under this treatment condition, and 58 % cytotoxicity (determined as 
reduction in RI) was achieved at the top concentration. These treatments resulted in frequencies of 
MNBN cells that were similar to concurrent controls and there were no significant differences.  
Considering that the significant increase in MNBN cell frequencies in the first experiment were not 
reproduced in the second one, the Panel concluded that 4-methylpent-3-en-2-one [FL-no: 07.101] did 
not induce micronuclei in cultured human peripheral blood lymphocytes when tested up to toxic 
concentrations in both the absence and presence of S9-mix metabolism (Stone, 2011). 
For a summary of in vitro genotoxicity data considered by EFSA, see Table 8. 
Discussion of Mutagenicity/Genotoxicity Data 
The representative substance 4-methylpent-3-en-2-one [FL-no: 07.101] is considered negative in the 
Ames test with S. typhimurium tester strains consistent with the requirements for current regulatory 
guidelines. Statistically significant increase in the number of revertant colonies observed in tester 
strain TA1535 in the absence of S9-mix metabolism in one experiment following treatment with 4-
methylpent-3-en-2-one are judged not biologically relevant, since they were not reproduced in the 
second experiment (Williams, 2009b; Ballantyne, 2011).  
Investigations at chromosome and genome levels in mammalian cells in vitro  showed that 4-
methylpent-3-en-2-one induced a small but statistically significant increase in the frequency of 
micronucleated binucleate cells (MNBN) only in the presence of S9-mix metabolism following a 
three hour treatment at the highest concentration tested (981.4 µg/ml). However, only one replicate 
culture fell outside the historical vehicle control range values. Following additional scoring of 2000 
erythrocytes, the resulting MNBN frequencies, although still significantly higher than concurrent 
vehicle control, lied within historical control range values. In a second confirmatory experiment (3-Flavouring Group Evaluation 63, Revision 2 
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hour treatment in the presence of S9-mix) performed at concentrations lower than concentrations used 
in the previous experiment, due to an unexplained shift of toxicity (comparable toxicity to those 
observed in the first experiment, but at lower concentrations), no significant increase in MNBN 
frequencies was observed. Based on these results the Panel concluded that 4-methylpent-3-en-2-one 
did not induce micronuclei in human peripheral blood lymphocytes, both in the absence and presence 
of rat liver S9-mix metabolism. 
Conclusion on Genotoxicity  
The Panel noted that for 4-methylpent-3-en-2-one [FL-no: 07.101], the data available showed that it 
did not induce mutations in bacteria or micronuclei in human peripheral blood lymphocytes, neither in 
the presence nor in the absence of rat liver S9-mix metabolic activation. Based on these findings, the 
Panel concluded that 4-methylpent-3-en-2-one does not present a safety concern with respect to 
genotoxicity and accordingly the flavouring substance can be evaluated using the Procedure.  
4.5.  EFSA Considerations 
The Panel concluded that the data available do not preclude evaluation of the 20 aliphatic secondary 
alcohols, ketones and related esters through the Procedure. 
5.  Application of the Procedure 
5.1.  Application of the Procedure to 20 Aliphatic Secondary Alcohols, Ketones and Related 
Esters by the JECFA (JECFA, 2003; JECFA, 2009b) 
According to the JECFA six of the substances belong to structural class I and 14 to structural class II 
using the decision tree approach presented by Cramer et al. (Cramer et al., 1978). 
The JECFA concluded all 20 aliphatic secondary alcohols, ketones and related esters at step A3 in the 
JECFA Procedure – i.e. the substances are expected to be metabolised to innocuous products (step 2) 
and the intakes for all substances are below the thresholds for their structural classes I and II (step 
A3). 
In conclusion, the JECFA evaluated all 20 substances as to be of no safety concern at the estimated 
levels of intake as flavouring substances based on the MSDI approach. 
The evaluations of the 20 aliphatic secondary alcohols, ketones and related esters are summarised in 
Table 9: Summary of Safety Evaluation of Aliphatic Secondary Alcohols, Ketones and Related Esters 
(JECFA, 2003; JECFA, 2009b). 
5.2.  Application of the Procedure to 49 Saturated and Unsaturated Aliphatic Secondary 
Alcohols, Ketones and Esters of Secondary Alcohols and Saturated Linear or 
Branched-chain Carboxylic Acids  by EFSA, FGE.07Rev4  (EFSA  Panel on Food 
Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 2012a) 
Twenty-eight of the candidate substances [FL-no: 02.077, 02.124, 02.142, 02.148, 02.177, 02.182, 
02.183, 02.190, 02.255,  07.084, 07.178, 07.239, 09.304, 09.323, 09.325, 09.328, 09.332, 09.386, 
09.388, 09.391, 09.604, 09.605, 09.606, 09.608, 09.609, 09.676, 09.880 and 09.926] are classified 
into structural class I, according to the decision tree approach presented by Cramer et al. (Cramer et 
al., 1978). The remaining 21 candidate substances [FL-no: 02.145, 02.194, 02.211, 07.072, 07.150, 
07.156, 07.157, 07.158, 07.160, 07.162, 07.181, 07.182, 07.185, 07.189, 07.198,  07.199, 07.201, Flavouring Group Evaluation 63, Revision 2 
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07.204, 07.205, 07.236 and 07.262], which are unsaturated aliphatic secondary alcohols or acyclic 
aliphatic saturated or unsaturated ketones, are in structural class II. 
Forty-eight substances were concluded at step A3 using the EFSA Procedure – i.e. the substances are 
expected to be metabolised to innocuous products (step 2) and the estimated daily intakes for 48 
substances are below the thresholds of concern for their structural classes (step A3). 
One candidate substance, 5-methylheptan-3-one  [FL-no: 07.182],  cannot be predicted to be 
metabolised to innocuous products and therefore, proceeds to step B3. The estimated daily intake of 
this substance of 0.32 microgram/capita/day does not exceed the threshold of concern for structural 
class II (540 microgram/person/day). Accordingly, the candidate substance proceeds to step B4 of the 
Procedure. On the basis of a study on the neurotoxic effects of orally administered 5-methylheptan-3-
one [FL-no: 07.182] to male rats, a NOAEL of 82 mg/kg body weight (bw)/day was established (IBM 
Corp., 1989). This NOAEL provides a margin of safety of 1.5 x 10
7 based on the estimated intake of 
the candidate substance of 0.32 microgram/capita/day. Based on results of the safety evaluation 
sequence this candidate substance does not pose a safety concern when used as flavouring substance 
at the estimated level of intake, based on the MSDI approach. 
The stepwise evaluations of the 49 substances are summarised in Table 10: Summary of Safety 
Evaluation Applying the Procedure (EFSA Panel on Food Contact Materials, Enzymes, Flavourings 
and Processing Aids (CEF), 2012a). 
5.3.  EFSA Considerations 
The Panel agrees with the application of the Procedure as performed by the JECFA for the 20 
substances in the group of aliphatic secondary alcohols, ketones and related esters. 
CONCLUSIONS  
In Flavouring Group Evaluation 63, Revision 1 (FGE.63Rev1) the EFSA considered 19 flavouring 
substances  (EFSA  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF), 2012c) from two groups of flavouring substances consisting of aliphatic secondary alcohols, 
ketones and related esters evaluated by the JECFA at its 59
th meeting (JECFA, 2003) and its 69
th 
meeting (JECFA, 2009b). The present revision of FGE.63, FGE.63Rev2, includes the consideration of 
one additional substance, 4-methylpent-3-en-2-one [FL-no: 07.101]. This substance was evaluated by 
the JECFA at its 69
th  meeting  (JECFA, 2009b).  It  was  originally allocated to and evaluated in 
FGE.204 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF), 
2012d) in which it was considered not to be of concern with respect to genotoxicity. 
Therefore, the present revision of FGE.63, FGE.63Rev2,  considers  20  flavouring substances 
evaluated by the JECFA.  
The Panel concluded that the additional substance fits well together with the 19 aliphatic secondary 
alcohols, ketones and related esters considered in the FGE.63Rev1. 
The Panel concluded that the 20 substances in the JECFA flavouring group of aliphatic secondary 
alcohols, ketones and related esters are structurally related to the group of 49 saturated and 
unsaturated aliphatic secondary alcohols, ketones and esters of secondary alcohols and saturated 
linear or branched-chain carboxylic acids evaluated in FGE.07Rev4. 
The Panel agrees with the application of the Procedure as performed by the JECFA for the 20 
substances considered in this FGE.  Flavouring Group Evaluation 63, Revision 2 
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For  all  20  substances,  the JECFA evaluation is based on MSDI values derived from production 
figures from the EU. 
For three candidate substances [FL-no: 02.252, 07.190 and 09.936], the Industry has submitted normal 
and maximum use levels. For [FL-no: 02.252 and 09.936], which are expected to be metabolised to 
innocuous products, the mTAMDI values are below their respective thresholds of concern for 
structural class I (1800 microgram/person/day) and class II  (540 microgram/person/day).  For 
substance [FL-no: 07.190], the mTAMDI value is above the threshold of concern for structural class 
II of 540 microgram/person/day to which it is allocated. Therefore, for this substance more reliable 
exposure data are required. On the basis of such additional data, the flavouring substance should be 
reconsidered along the steps of the Procedure. Following this procedure, additional toxicological data 
might become necessary. For the remaining 17 substances evaluated through the Procedure, use levels 
are needed to calculate the mTAMDIs in order to identify those flavouring substances that need more 
refined exposure assessment in order to finalise the evaluation. 
In order to determine whether the conclusion for the 20 JECFA-evaluated substances can be applied 
to the materials of commerce, it is necessary to consider the available specifications.  Adequate 
specifications including complete purity criteria and identity are available for all 20 JECFA-evaluated 
substances.  
Thus, for all 20 JECFA evaluated aliphatic secondary alcohols, ketones and related esters [FL-no: 
02.252,  07.015, 07.069, 07.099,  07.100,  07.101,  07.114,  07.123, 07.151, 07.190, 07.240, 07.247, 
07.249, 07.256, 09.657, 09.658, 09.923, 09.924, 09.925 and 09.936] the Panel agrees with the JECFA 
conclusion “No safety concern at estimated levels of intake as flavouring substances” based on the 
MSDI approach. 
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Table 3:   Specification Summary of the Substances in the JECFA Flavouring Groups of Aliphatic Secondary Alcohols, Ketones and related Esters 
(JECFA, 2002d; JECFA, 2009b) 
Table 3: Specification Summary of the Substances in the JECFA Flavouring Groups of Aliphatic Secondary Alcohols, Ketones and related Esters (JECFA, 2002b; 
JECFA, 2009a) 
FL-no 
JECFA-
no 
EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 
4) 
Spec.gravity 
5) 
EFSA comments 
02.252 
1841 
4,8-Dimethyl-3,7-nonadien-2-ol 
OH
 
4102 
 
67845-50-5 
Liquid 
C11H20O 
168 
Insoluble 
Soluble 
70 (2.6 hPa) 
 
IR NMR 
95 % 
1.465-1.473 
0.860-0.870 
 
Racemate. Mixture of E/Z 
stereoisomers: 50-80 % (E) 
(EFFA, 2012). 
07.015 
1120 
6-Methylhept-5-en-2-one 
O
 
2707 
149 
110-93-0 
Liquid 
C8H14O 
126.19 
Insoluble 
Miscible 
173.1 
 
NMR 
97 % 
1.435-1.445 
0.846-0.854 
 
 
07.069 
1121 
Tetrahydro-pseudo-ionone 
O
 
3059 
2053 
4433-36-7 
Liquid 
C13H24O 
196.33 
Insoluble 
Miscible 
234 
 
NMR 
95 % 
1.449-1.455 
0.865-0.875 
 
Racemate (EFFA, 2010). 
07.099 
1134 
6-Methylhepta-3,5-dien-2-one 
O
 
3363 
11143 
1604-28-0 
Liquid 
C8H12O 
124.18 
Almost insoluble 
Miscible 
190 
 
NMR 
96 % 
1.528-1.537 
0.895-0.899 
 
Mixtureof E/Z stereoisomers: 
60-90 % (E) (EFFA, 2012). 
07.100 
1119 
5-Methylhex-5-en-2-one 
O
 
3365 
11150 
3240-09-3 
Liquid 
C7H12O 
112.17 
Insoluble 
Miscible 
148-149 
 
NMR 
97 % 
1.428-1.433 
0.862-0.868 
 
 
07.101 
1131 
4-Methylpent-3-en-2-one 
O
 
3368 
11853 
141-79-7 
Liquid 
C6H10O 
98.14 
Slightly soluble 
Miscible 
126.76 
 
NMR 
95 % 
1.442-1.447 
0.862-0.868 
 
 
07.114 
1123 
6,10,14-Trimethylpentadeca-5,9,13-
trien-2-one 
O
(5E), (9E)-isomer shown  
3442 
11206 
762-29-8 
Liquid 
C18H30O 
262.44 
Soluble 
Miscible 
147-148 
 
NMR 
96 % 
1.478-1.483 
0.885-0.895 
 
Mixture of (5E,9E)-, 
(5Z,9Z)-, (5E,9Z)- and 
(5Z,9E)-isomers (EFFA, 
2010). 
07.123 
1122 
Geranylacetone 
O
 
3542 
11088 
3796-70-1 
Liquid 
C13H22O 
194.32 
Slightly soluble 
Miscible 
247 
 
NMR 
95 % 
1.463-1.471 
0.861-0.867 
 
 
07.151 
1118 
Decan-3-one 
O
 
3966 
11056 
928-80-3 
Liquid 
C10H20O 
156.27 
Insoluble 
Miscible 
204-205 
 
NMR 
97 % 
1.421-1.427 
0.820-0.830 
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Table 3: Specification Summary of the Substances in the JECFA Flavouring Groups of Aliphatic Secondary Alcohols, Ketones and related Esters (JECFA, 2002b; 
JECFA, 2009a) 
FL-no 
JECFA-
no 
EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 
4) 
Spec.gravity 
5) 
EFSA comments 
07.190 
1848 
Octa-1,5-dien-3-one 
O
 
4405 
 
65213-86-7 
Liquid 
C8H12O 
124.18 
Practically insoluble or 
insoluble 
Freely soluble 
169 
 
MS 
95 % 
1.438-1.444 
0.823-0.829 
 
Mixture of E/Z 
stereoisomers: 60-90 % (E) 
(EFFA, 2012). 
07.240 
1156 
2-Methylheptan-3-one 
O
 
4000 
 
13019-20-0 
Liquid 
C8H16O 
128.2 
Insoluble 
Miscible 
158-160 
 
NMR 
98 % 
1.408-1.413 
0.811-0.821 
 
 
07.247 
1139 
(E,E)-3,5-Octadien-2-one 
O
 
4008 
 
30086-02-3 
Liquid 
C8H12O 
124.2 
Insoluble 
Miscible 
220 
 
NMR 
95 % 
1.508-1.516 
0.880-0.890 
 
 
07.249 
1155 
Undecan-6-one 
O
 
4022 
 
927-49-1 
Liquid 
C11H22O 
170.3 
Insoluble 
Miscible 
228 
 
NMR 
97 % 
1.424-1.430 
0.826-0.836 
 
 
07.256 
1137 
(3Z)-4,8-Dimethyl-3,7-nonadiene-2-
one  O
 
3969 
 
817-88-9 
Liquid 
C11H18O 
166.26 
Insoluble 
Freely soluble 
200-201 
n.a. 
IR NMR 
94 % 
1.473-1.477 
0.869-0.875 
 
Mixture of E/Z 
stereoisomers: 60-90 % (E) 
(EFFA, 2012). Register 
name to be changed to 4,8-
Dimethyl-3,7-nonadiene-2-
one.  
09.657 
1146 
1-Methylbutyl acetate 
O
O
 
4012 
10761 
626-38-0 
Liquid 
C7H14O2 
130.2 
Insoluble 
Partially Soluble 
135 
 
NMR 
98 % 
1.369-1.400 
0.862-0.866 
 
Racemate (EFFA, 2010).  
09.658 
1142 
1-Methylbutyl butyrate 
O
O
 
3893 
10763 
60415-61-4 
Liquid 
C9H18O2 
158.24 
Insoluble 
50% Soluble 
185-186 
 
IR NMR MS 
99 % 
1.409-1.415 
0.862-0.868 
 
Racemate (EFFA, 2010). 
09.923 
1144 
Hept-2-yl butyrate 
O O  
3981 
 
39026-94-3 
Liquid 
C11H22O2 
186.3 
Insoluble 
Miscible 
210 
 
NMR 
98 % 
1.413-1.417 
0.855-0.860 
 
Racemate (EFFA, 2010).  
09.924 
1143 
(+/-)-3-Heptyl acetate 
O
O
 
3980 
 
5921-83-5 
Liquid 
C9H18O2 
158.2 
Insoluble 
Miscible 
185 
 
NMR 
98 % 
1.406-1.414 
0.858-0.867 
 
Racemate. Register name to 
be changed to 3-Heptyl 
acetate. 
09.925 
1145 
Nonan-3-yl acetate 
O
O
 
4007 
 
60826-15-5 
Liquid 
C11H22O2 
186.3 
Insoluble 
Miscible 
225 
 
NMR 
98 % 
1.416-1.423 
0.854-0.864 
 
Racemate (EFFA, 2010).  Flavouring Group Evaluation 63, Revision 2 
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Table 3: Specification Summary of the Substances in the JECFA Flavouring Groups of Aliphatic Secondary Alcohols, Ketones and related Esters (JECFA, 2002b; 
JECFA, 2009a) 
FL-no 
JECFA-
no 
EU Register name  Structural formula  FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 
2) 
Boiling point, °C 
3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 
4) 
Spec.gravity 
5) 
EFSA comments 
09.936 
1847 
4,8-Dimethyl-3,7-nonadien-2-yl 
acetate 
O
O
 
4103 
 
91418-25-6 
Liquid 
C13H22O2 
210 
Insoluble 
Soluble 
75-83 (3 hPa) 
 
IR NMR 
95 % 
1.451-1.459 
0.890-0.900 
 
Racemate. Mixture of E/Z 
stereoisomers: 50-80 % (E) 
(EFFA, 2012). 
1)  Solubility in water, if not otherwise stated. 
2)  Solubility in 95 % ethanol, if not otherwise stated. 
3)  At 1013.25 hPa, if not otherwise stated. 
4)  At 20°C, if not otherwise stated. 
5)  At 25°C, if not otherwise stated. 
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Table 4:   Summary of Genotoxicity Data of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003) 
Table 4: Summary of Genotoxicity Data of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003) 
FL-no 
JECFA-
no 
EU Register name 
JECFA name 
Structural formula  End-point  Test system  Concentration  Results  Reference 
In vitro 
07.015 
1120 
6-Methylhept-5-en-2-one 
O
 
Reverse mutation  S. typhimurium TA98, TA100, 
TA1535, TA1537 
380 µg/plate  Negative
1  (Florin et al., 1980) 
07.099 
1134 
6-Methyl-3,5-heptadien-2-
one 
O
 
Reverse mutation  S. typhimurium TA98, TA100, 
TA1535, TA1537 
370 µg/plate  Negative
1  (Florin et al., 1980) 
1   With and without metabolic activation. 
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Table 5:   Summary of Genotoxicity Data (in vitro)  EFSA / FGE.07Rev4 (EFSA  Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF), 2012a) (substances in brackets are JECFA-evaluated substances) 
Table 5: Summary of Genotoxicity Data (in vitro) EFSA / FGE.07Rev4 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF), 2012a) (substances in brackets are JECFA-evaluated substances) 
Chemical Name [Fl.No.]  Test system  Test Object  Concentration  Result  Reference  Comments 
(Acetone [07.050])  Rec assay  B. subtilis  NR  Negative 
1  (Kawachi et al., 1980)  8 
Rec assay  B. subtilis  NR  Negative  (Ishizaki et al., 1979)  8 
Ames test  S. typhimurium TA100  0.1 to 1000 µg/plate  Negative  (Rapson et al., 1980)  8 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537 
174 µg/plate  Negative 
1  (Florin et al., 1980)  8 
Ames test  S. typhimurium TA98, TA100  NR  Negative 
1  (Kawachi et al., 1980)  8 
Ames test 
2  S. typhimurium TA98, TA100  30 µl/plate  Negative 
4  (Yamaguchi, 1985)  8 
Ames test  S. typhimurium TA97, TA98, 
TA100, TA1535, TA1537 
Up to 10000 µg/plate  Negative 
1  (McCann et al., 1975)  8 
Ames test 
2  S. typhimurium TA97, TA98, 
TA100, TA1535, TA1537 
Up to 10000 µg/plate  Negative 
1  (Zeiger et al., 1992)  8 
Ames test  S. typhimurium TA100  500 µg/plate  Negative 
1  (Yamaguchi, 1982)  8 
Ames test  S. typhimurium TA97, TA98, 
TA100 
20 to 40 µg  Negative 
1  (Azizan and Blevins, 1995)  8 
Sister chromatid exchange  Human embryo fibroblasts  NR  Negative 
4  (Kawachi et al., 1980)  8 
Sister chromatid exchange  Hamster lung fibroblasts  NR  Negative 
4  (Kawachi et al., 1980)  8 
Sister chromatid exchange  Chinese hamster ovary cells  Up to 10 µg/ml  Negative  (Sasaki et al., 1980)  8 
Sister chromatid exchange  Chinese hamster ovary cells  Up to 5020 µg/ml  Negative 
1  (Loveday et al., 1990)  8 
Sister chromatid exchange  Diploid human fibroblasts  5 µg/ml  Negative  (Sasaki et al., 1980)  8 
Sister chromatid exchange  Human lymphocytes  395 µg/ml  Negative  (Norppa et al., 1983)  8 
Sister chromatid exchange  Human lymphocytes  0.1 to 1 mM  Negative  (Zarani et al., 1999)  8 
Chromosomal aberrations  Chinese hamster ovary cells  Up to 5020 µg/ml  Negative 
1  (Loveday et al., 1990)  8 
Chromosomal aberrations  Hamster lung fibroblasts  NR  Positive 
4  (Kawachi et al., 1980)  8 
Aneuploidy induction  S. cerevisiae  6.98-7.83 %  Positive 
4  (Zimmermann et al., 1985)  10 
(Isopropyl alcohol [02.079])  Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537 
174 µg/plate  Negative 
1  (Florin et al., 1980)  8 
Ames test 
2  S. typhimurium TA98, TA100, 
TA1535, TA1537, E. coli WP2uvrA 
5 to 5000 µg/plate  Negative 
1  (Shimizu et al., 1985)  8 
Ames test 
2  S. typhimurium TA97, TA98, 
TA100, TA102, TA104, TA1535, 
TA1537 
Up to 10 mg/plate 
5  Negative 
1  (Zeiger et al., 1992)  8 
Forward mutation  Chinese hamster ovary cells 
6  0.5 to 5.0 mg/ml  Negative 
1  (CMA, 1990)  8 
Forward mutation  Chinese hamster ovary cells 
6  0.5 to 5.0 mg/ml  Negative 
1  (Kapp et al., 1993)  8 
(2-Butanone [07.053])  Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
10000 µg/plate  Negative 
1  (Douglas et al., 1980)  8 
Ames test  S. typhimurium TA102, TA104  1 mg/plate  Negative  (Marnett et al., 1985)  8 
(2-Butanone [07.053]) 
continued 
Ames test 
2  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
5 to 5000 µg/plate  Negative 
1  (Shimizu et al., 1985)  8 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
0.04 to 26 µg/plate  Negative 
1  (O’Donoghue et al., 1988)  8 Flavouring Group Evaluation 63, Revision 2 
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Table 5: Summary of Genotoxicity Data (in vitro) EFSA / FGE.07Rev4 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF), 2012a) (substances in brackets are JECFA-evaluated substances) 
Chemical Name [Fl.No.]  Test system  Test Object  Concentration  Result  Reference  Comments 
Ames test 
2  S. typhimurium TA97, TA98, 
TA100, TA104, TA1535, TA1537 
Up to 10000 µg/plate  Negative 
1  (Zeiger et al., 1992)  8 
Ames test  S. typhimurium TA102  5000 µg/plate  Negative 
4  (Müller et al., 1993)  8 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538,  
E. coli WP2uvrA 
4000 µg/plate  Negative  (Brooks et al., 1988)  8 
Gene conversion  S. cerevisiae  5 mg/ml  Negative 
1  (Brooks et al., 1988)  8 
Forward Mutation  L5178Y/TL+/- mouse lymphoma 
cells 
0.67 to 12 µg/ml  Negative 
1  (O’Donoghue et al., 1988)  8 
Unscheduled DNA 
synthesis 
Human lymphocytes  0.72 mg/ml  Negative 
1  (Perocco et al., 1983)  8 
Unscheduled DNA 
synthesis 
Rat hepatocytes  7.2 to 360 mg/ml  Negative  (O’Donoghue et al., 1988)  8 
Chromosomal aberrations  Rat hepatocytes  1000 µg/ml  Negative  (Brooks et al., 1988)  8 
Chromosomal aberrations  Chinese hamster ovary cells  1000 µg/ml  Negative 
1  (Brooks et al., 1988)  8 
Cell transformation assay
1  BALB/3T3 cells (clone A31-1)  6-18 µl/ml  Negative  (O’Donoghue et al., 1988)   
Aneuploidy induction  S. cerevisiae  3.38 %  Positive 
4  (Zimmermann et al., 1985)  11 
Pentan-3-one [07.084]  Aneuploidy induction  S. cerevisiae  1.48 %  Positive 
4  (Zimmermann et al., 1985)  11 
Pentan-3-ol [02.077]  Chromosomal aberrations  Chinese hamster ovary cells  0.5 to 10 %  Negative 
1  (Abbondandolo et al., 1980)   
Forward mutation  S. pombe  0.5 to 10 %  Negative 
1  (Abbondandolo et al., 1980)   
(2-Heptanone [07.002])  Unscheduled DNA 
synthesis 
Rat hepatocytes  1000 ppm  Negative  (Barber et al., 1999)   
Methyl-3-butan-2-one 
[07.178] 
Aneuploidy induction  S. cerevisiae  1.23 to 1.36 %  Negative 
4  (Zimmermann et al., 1985)  11 
Aneuploidy induction  S. cerevisiae  0.84 to 1.23 %  Negative 
4  (Zimmermann et al., 1985)  11 
(4-Methyl-2-pentanone 
[07.017]) 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
0.03 to 3 mg/plate  Negative 
1  (O’Donoghue et al., 1988)  8 
Ames test 
2  S. typhimurium TA97, TA98, 
TA100, TA1535 
Up to 6667 µg/plate  Negative 
1  (Zeiger et al., 1992)  8 
Ames test  E. coli WP2uvrA  8000 µg/plate  Negative 
4  (Brooks et al., 1988)  8 
Gene conversion  S. cerevisiae  5 mg/ml  Negative 
1  (Brooks et al., 1988)  8 
Forward mutation  L5178Y/TL+/- mouse lymphoma 
cells 
0.26 to 3.7 µg/ml  Negative 
1  (O’Donoghue et al., 1988)  8 
Unscheduled DNA 
synthesis 
Rat hepatocytes  8 to 80 µg/ml  Negative  (O’Donoghue et al., 1988)  8 
Chromosomal aberrations  Rat hepatocytes  1000 µg/ml  Negative  (Brooks et al., 1988)  8 
Cell transformation assay
1  BALB/3T3 cells (clone A31-1)  1-7µl/ml  Negative  (O’Donoghue et al., 1988)   
Chromosomal aberrations  Chinese hamster ovary cells  1000 µg/ml  Negative 
1  (Brooks et al., 1988)  8 
Methyl-4-pentan-2-ol 
[02.183] 
Ames test 
2  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538, E. coli 
WP2uvrA 
5000 µg  Negative 
1  (Shimizu et al., 1985)   
Methyl-6-heptan-2-one 
[07.181] 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537 
5000 µg/plate  Negative 
1  (BASF, 1989a)   
(2,6-Dimethyl-4-heptanone 
[07.122]) 
Ames test 
2  S. typhimurium TA98, TA100, 
TA1535, TA1537 
1 to 333 µg/plate  Negative 
1  (Mortelmans et al., 1986)  8 
Trimethyl-6,10,14-
pentadecan-2-one [07.205] 
Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537 
5000 µg/plate  Negative 
1  (BASF, 1989b)   Flavouring Group Evaluation 63, Revision 2 
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Table 5: Summary of Genotoxicity Data (in vitro) EFSA / FGE.07Rev4 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF), 2012a) (substances in brackets are JECFA-evaluated substances) 
Chemical Name [Fl.No.]  Test system  Test Object  Concentration  Result  Reference  Comments 
(6-Methyl-5-hepten-2-one 
[07.015]) 
Reverse mutation  S. typhimurium TA98, TA100, 
TA1535, TA1537 
380 µg/plate  Negative 
1  (Florin et al., 1980)  9 
(Isopropyl acetate [09.003])  Ames test 
2  S. typhimurium TA97, TA98, 
TA100, TA1537, TA1538 
Up to 10 mg/plate  Negative 
1  (Zeiger et al., 1992)  8 
(Isopropyl myristate 
[09.105]) 
Ames test 
7  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
50 µg/plate  Negative 
1  (Blevins and Taylor, 1982)  8 
Isopropyl hexadecanoate 
[09.606] 
Ames test 
7  S. typhimurium TA98, TA100, 
TA1535, TA1537, TA1538 
50 µg/plate  Negative 
1  (Blevins and Taylor, 1982)   
9-Decen-2-one [07.262]  Ames test
10  S. typhimurium TA98, TA100, 
TA1535, TA1537 
Up to 5 µL/plate  Negative
1  (Flavour Industry, 2009)   
Ames test
10  E. coli WP2 (pKM 101)  Up to 5 µL/plate  Negative
1  (Flavour Industry, 2009)   
(6-Methylhepta-3,5-dien-2-
one [07.099]) 
Reverse mutation  S. typhimurium TA98, TA100, 
TA1535, TA1537 
370 µg/plate  Negative
1  (Florin et al., 1980)  9 
Reverse Mutation  S. typhimurium TA98, TA100, 
TA1535, TA1537 and TA102 
1.6, 8, 40, 200, 1000 
and 5000 μg/plate   
Negative
1  (Williams, 2009a)  Toxicity observed in all strains at 2000 μg/plate or greater in 
the absence of S9 and at 800 μg/plate in the presence of S9. 
Study design complied with current recommendations. 
Acceptable top concentration was achieved. 
Micronucleus induction  Human peripheral blood 
lymphocytes 
225, 325 and 450 μg/ml 
13 225, 300 and 350 
μg/ml 
14 
Negative  (Whitwell, 2010)  Complies with draft OECD Guideline 487. Acceptable levels 
of cytotoxicity achieved at the top concentrations used in all 
parts of the study. 
Pseudo-ionone [07.198]  Ames test  S. typhimurium TA98, TA100, 
TA1535, TA1537 
0.03 to 30 µmol/plate  Negative  (Florin et al., 1980)   
Reverse Mutation  S. typhimurium TA98, TA100, 
TA1535, TA1537 and TA 102 
0.128, 0.64, 3.2, 16, 80, 
400 and 2000 μg/plate  
Negative
1  (Beevers, 2009)  Toxicity was observed in all strains at 400 μg/plate and 
greater in the presence and absence of S9 in this experiment. 
0.12.5, 25, 50, 100, 200 
and 400 μg/plate 
12 
Negative
1  Precipitation was observed in the 400 μg/plate concentration 
in the presence and absence of S9 in this experiment. Study 
design complies with current recommendations. Acceptable 
top concentrations were achieved. 
Micronucleus induction  Human peripheral blood 
lymphocytes 
30, 50 and 60 μg/ml
13 
100, 110 and 120 
μg/ml
14 
Negative  (Lloyd, 2010)  Complies with draft OECD Guideline 487. Acceptable levels 
of cytotoxicity achieved at the top concentrations used in all 
parts of the study. 
Micronucleus induction  Human peripheral blood 
lymphocytes 
10, 15 and 20 μg/ml
15  Negative  (Lloyd, 2010)  Complies with draft OECD Guideline 487. Acceptable levels 
of cytotoxicity achieved at the top concentrations used in all 
parts of the study. 
1. Assay performed with and without metabolic activation. 
2. Modified Ames (Pre-incubation) protocol. 
3. Assay performed with S9 metabolic activation. 
4. Assay performed without S9 metabolic activation. 
5. Maximum non-toxic dose. 
6. HGPRT locus. 
7. Spot test. 
8. Summarised by JECFA, 51
st meeting (JECFA, 1999). 
9. Summarised by JECFA 59
th meeting (JECFA, 2003). 
10. Direct incorporation method. 
11. Unusual experimental protocol for detection of aneuploidy, which can be considered a threshold effect not mediated by a direct interaction with DNA. Positive results were obtained at concentrations approaching cytotoxic levels and are very 
likelydue to the presence of technical artefacts (low temperature treatment inducing tubulin dissociation). Indeed, absence of effect was recorded when the ice treatment was skipped. – The limited relevance of fungal systems together with the 
uncertainquality of these results make questionable their extrapolation to the in vivo situation in humans. Flavouring Group Evaluation 63, Revision 2 
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12. Assay modified with pre-incubation in the presence of S9. 
13. Without metabolic activation, 3 hours treatment + 21 hours recovery. 
14. With metabolic activation, 3 hours treatment + 21 hours recovery. 
15. Without metabolic activation, 24 hours + 0 hours recovery. Flavouring Group Evaluation 63, Revision 2 
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Table 6:   Summary of Genotoxicity Data (in vivo)  EFSA / FGE.07Rev4 (EFSA  Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF), 2012a) (substances in brackets are JECFA-evaluated substances) 
Table 6: Summary of Genotoxicity Data (in vivo) EFSA / FGE.07Rev4 (EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF), 2012a) (substances in brackets are JECFA-evaluated substances) 
Chemical Name  Test system  Test Object  Route  Dose  Result  Reference  Comments 
(Isopropyl alcohol [02.079])  Micronucleus test   ICR Mouse (15M & 15F)   i.p. injection in 0.9 % NaCl  350-2500 mg/kg  Negative  (Kapp et al., 1993)  1 
(Acetone [07.050])  Micronucleus test  Chinese hamster (5M & 5F)  i.p. injection in corn oil  865 mg/kg  Negative  (Basler, 1986)  1 
(2-Butanone [07.053])  Micronucleus test  CD-1 mice (5M & 5F)  i.p. injection in corn oil  LD20 (1.96 ml/kg)  Negative  (O’Donoghue et al., 1988)  1 
Micronucleus test  Chinese hamster (5M & 5F)  i.p. injection in corn oil  411mg/kg  Negative  (Basler, 1986)  1 
(4-Methyl-2-pentanone 
[07.017]) 
Micronucleus test  CD-1 mice (5M & 5F)  i.p. injection in corn oil  LD20 (0.73 ml/kg)  Negative  (Basler, 1986)  1 
1. Summarised by JECFA, 51
st meeting (JECFA, 1999). Flavouring Group Evaluation 63, Revision 2 
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Table 7:   Genotoxicity (in vitro) Summary of Additionally submitted genotoxicity data on the representative substance of subgroup 1.2.3 (FGE.206) 
Table 7: Genotoxicity (in vitro) Summary of Additionally submitted genotoxicity data on the representative substance of subgroup 1.2.3 
FL-no  Chemical Name  Test System in vitro   Test Object   Concentrations of Substance and 
Test Conditions  
Result   Reference   Comments  
[07.099]  6-Methylhepta-3,5-dien-2-
one  
Reverse Mutation  S. typhimurium TA98, 
TA100, TA1535, TA1537 
and TA 102 
1.6, 8, 40, 200, 1000 and 5000 
μg/plate [1]  
Negative  (Williams, 
2009a) 
Toxicity observed in all strains at 2000 μg/plate or 
greater in the absence of S9 and at 800 μg/plate in the 
presence of S9. Study design complied with current 
recommendations. Acceptable top concentration was 
achieved. 
20.48, 51.2, 128, 320, 800, 2000 
and 5000 μg/plate [1,2] 
Negative 
Micronucleus induction  Human peripheral blood 
lymphocytes 
225, 325 and 450 μg/ml [3] 225, 
300 and 350 μg/ml [4] 
Negative  (Whitwell, 
2010) 
Complies with draft OECD Guideline 487. Acceptable 
levels of cytotoxicity achieved at the top concentrations 
used in all parts of the study. 
100, 120 or 150 μg/ml [5]  Negative 
[1] With and without metabolic activation. 
[2] Assay modified with pre-incubation in the presence of S9. 
[3] Without metabolic activation, 3 hours treatment + 21 hours recovery. 
[4] With metabolic activation, 3 hours treatment + 21 hours recovery. 
[5] Without metabolic activation, 24 hours + 0 hours recovery. Flavouring Group Evaluation 63, Revision 2 
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Table 8:   Genotoxicity (in vitro) Summary of Additionally submitted genotoxicity data on the representative substance of subgroup 1.2.1 (FGE.204) 
Table 8: Genotoxicity (in vitro) Summary of Additionally submitted genotoxicity data on the representative substance of subgroup 1.2.1 
FL-no  Chemical Name  Test System in vitro   Test Object   Concentrations of Substance and 
Test Conditions  
Result   Reference   Comments  
[07.101]  4-Methylpent- 3-en-2-one  Reverse Mutation  S.typhimurium 
TA98, TA100, TA102, 
TA1535 and TA1537 
1.6 - 5000 μg/plate [1]  Negative  (Williams, 2009b)  Valid. 
Study design complies with current 
recommendations.  156.25 - 5000 μg/plate [1,2]  Negative 
Micronucleus Assay  Human peripheral blood 
lymphocytes 
600 - 981.4 μg/ml [3]  Negative  (Stone, 2011)  Valid 
Complies with OECD Guideline 487. 
200 - 981.4 μg/ml [4]  Negative 
100 - 500 μg/ml [4]  Negative 
100 - 300 μg/ml [5]  Negative 
Validity of genotoxicity studies: 
Valid. 
Limited validity (e.g. if certain aspects are not in accordance with OECD Guidelines or current standards and / or limited documentation). 
Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards inappropriate / not validated test system). 
Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided, text not in a Community language). 
 
[1]  With and without S9-mix metabolic activation. 
[2]  Assay modified with pre-incubation in the presence of S9-mix. 
[3]  Without metabolic activation, 3 hours treatment + 21 hours recovery. 
[4]  With metabolic activation, 3 hours treatment + 21 hours recovery. 
[5]  Without metabolic activation, 24 hours + 0 hours recovery. Flavouring Group Evaluation 63, Revision 2 
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Table 9:   Summary of Safety Evaluation of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003; JECFA, 
2009b) 
Table 9: Summary of Safety Evaluation of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003; JECFA, 2009b) 
FL-no 
JECFA-no 
EU Register name  Structural formula  EU MSDI 1)  
US MSDI 
(µg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on 
the material of 
commerce 
02.252 
1841 
4,8-Dimethyl-3,7-nonadien-2-ol 
OH
 
3 
0.1 
Class I 
A3: Intake below threshold 
4)  Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at the estimated 
level of intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
09.657 
1146 
1-Methylbutyl acetate 
O
O
 
2.9 
3 
Class I 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
09.658 
1142 
1-Methylbutyl butyrate 
O
O
 
0.47 
1 
Class I 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
09.923 
1144 
Hept-2-yl butyrate 
O O  
3.0 
3 
Class I 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
09.924 
1143 
(+/-)-3-Heptyl acetate 
O
O
 
3.0 
3 
Class I 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
Register name to be 
changed to 3-Heptyl 
acetate.  
09.925 
1145 
Nonan-3-yl acetate 
O
O
 
3.0 
3 
Class I 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.015 
1120 
6-Methylhept-5-en-2-one 
O
 
100 
44 
Class II 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.069 
1121 
Tetrahydro-pseudo-ionone 
O
 
0.012 
0.01 
Class II 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. Flavouring Group Evaluation 63, Revision 2 
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Table 9: Summary of Safety Evaluation of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003; JECFA, 2009b) 
FL-no 
JECFA-no 
EU Register name  Structural formula  EU MSDI 1)  
US MSDI 
(µg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on 
the material of 
commerce 
07.099 
1134 
6-Methylhepta-3,5-dien-2-one 
O
 
13 
5 
Class II 
A3: Intake below threshold 
4)  Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at the estimated 
level of intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.100 
1119 
5-Methylhex-5-en-2-one 
O
 
0.24 
0.3 
Class II 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.101 
1131 
4-Methylpent-3-en-2-one 
O
 
0.34 
ND 
Class II 
A3: Intake below threshold 
4)  Evaluated in FGE.204, 
genotoxicity concern could 
be ruled out. No safety 
concern at the estimated 
level of intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.114 
1123 
6,10,14-Trimethylpentadeca-5,9,13-
trien-2-one 
O
(5E), (9E)-isomer shown  
0.085 
ND 
Class II 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.123 
1122 
Geranylacetone 
O
 
41 
2 
Class II 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
CASrn refers to (E)-
isomer. 
07.151 
1118 
Decan-3-one 
O
 
3.0 
3 
Class II 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
07.190 
1848 
Octa-1,5-dien-3-one 
O
 
0.061 
ND 
Class II 
A3: Intake below threshold 
4)  Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at the estimated 
level of intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.240 
1156 
2-Methylheptan-3-one 
O
 
3.0 
3 
Class II 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
07.247 
1139 
(E,E)-3,5-Octadien-2-one 
O
 
3.0 
4 
Class II 
A3: Intake below threshold 
4)  Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at the estimated 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. Flavouring Group Evaluation 63, Revision 2 
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Table 9: Summary of Safety Evaluation of Aliphatic Secondary Alcohols, Ketones and related Esters Evaluated by the JECFA (JECFA, 2003; JECFA, 2009b) 
FL-no 
JECFA-no 
EU Register name  Structural formula  EU MSDI 1)  
US MSDI 
(µg/capita/day) 
 
Class 2) 
Evaluation procedure 
path 3) 
Outcome on the 
named compound  
[4) or 5)] 
EFSA conclusion on the 
named compound 
(Procedure steps, intake 
estimates, NOAEL, 
genotoxicity) 
 
EFSA conclusion on 
the material of 
commerce 
level of intake based on the 
MSDI approach. 
07.249 
1155 
Undecan-6-one 
O
 
3.0 
3 
Class II 
A3: Intake below threshold 
4)  No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety concern at 
estimated levels of 
intake based on the 
MSDI approach. 
07.256 
1137 
(3Z)-4,8-Dimethyl-3,7-nonadiene-2-
one  O
 
6.1 
6.6 
Class II 
A3: Intake below threshold 
4)  Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at the estimated 
level of intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach.  
Register name to be 
changed to 4,8-
Dimethyl-3,7-
nonadiene-2-one.  
 
09.936 
1847 
4,8-Dimethyl-3,7-nonadien-2-yl 
acetate 
O
O
 
3 
0.2 
Class II 
A3: Intake below threshold 
4)  Evaluated in FGE.206, 
genotoxicity concern could 
be ruled out. No safety 
concern at the estimated 
level of intake based on the 
MSDI approach. 
No safety concern at 
the estimated level of 
intake based on the 
MSDI approach. 
1)  EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2)  Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3)  Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4)  No safety concern based on intake calculated by the MSDI approach of the named compound. 
5)  Data must be available on the substance or closely related substances to perform a safety evaluation. 
ND: not determined Flavouring Group Evaluation 63, Revision 2 
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Table 10:   Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.07Rev4) 
Table 10: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.07Rev4) 
FL-no  EU Register name  Structural formula  MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation 
remarks 
02.077 
 
Pentan-3-ol 
OH
 
0.19 
 
Class I 
A3: Intake below threshold 
4)  6)   
02.124 
 
6-Methylhept-5-en-2-ol 
OH
 
0.0061 
 
Class I 
A3: Intake below threshold 
4)  6)   
02.142 
 
3,3-Dimethylbutan-2-ol 
OH
 
0.24 
 
Class I 
A3: Intake below threshold 
4)  6)   
02.148 
 
Dodecan-2-ol 
OH
 
0.35 
 
Class I 
A3: Intake below threshold 
4)  6)   
02.177 
 
2-Methylhexan-3-ol 
OH
 
0.12 
 
Class I 
A3: Intake below threshold 
4)  6)   
02.182 
 
3-Methylpentan-2-ol 
OH
 
0.12 
 
Class I 
A3: Intake below threshold 
4)  6)   
02.183 
 
4-Methylpentan-2-ol 
OH
 
0.0012 
 
Class I 
A3: Intake below threshold 
4)  6)   
02.190 
 
Nonan-3-ol 
OH
 
0.011 
 
Class I 
A3: Intake below threshold 
4)  6)   
02.255 
 
(Z)-4-Hepten-2-ol 
OH
 
0.03 
 
Class I 
A3: Intake below threshold 
4)  6)   
07.084 
 
Pentan-3-one 
O
 
0.24 
 
Class I 
A3: Intake below threshold 
4)  6)   
07.178 
 
3-Methylbutan-2-one 
O
 
0.073 
 
Class I 
A3: Intake below threshold 
4)  6)   
07.239 
1840 
[R-(E)]-5-Isopropyl-8-
methylnona-6,8-dien-2-one 
O
 
0.24 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.304 
 
sec-Heptyl isovalerate 
O
O
 
0.0012 
 
Class I 
A3: Intake below threshold 
4)  6)   Flavouring Group Evaluation 63, Revision 2 
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Table 10: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.07Rev4) 
FL-no  EU Register name  Structural formula  MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation 
remarks 
09.323 
 
sec-Butyl acetate 
O
O
 
0.0012 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.325 
 
sec-Butyl butyrate 
O
O
 
1.3 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.328 
 
sec-Butyl formate 
O
O
 
0.12 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.332 
 
sec-Butyl hexanoate 
O
O
 
0.024 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.386 
 
sec-Hept-4(cis)-enyl acetate 
O
O
 
0.024 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.388 
 
sec-Heptyl acetate 
O
O
 
0.12 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.391 
 
sec-Heptyl hexanoate 
O
O
 
0.12 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.604 
 
Isopropyl decanoate 
O
O
 
0.12 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.605 
 
Isopropyl dodecanoate 
O
O
 
0.12 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.606 
 
Isopropyl hexadecanoate 
O
O
 
0.012 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.608 
 
Isopropyl octanoate 
O
O
 
1.3 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.609 
 
Isopropyl valerate 
O
O  
0.012 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.676 
 
sec-Octyl acetate 
O
O
 
0.011 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.880 
 
Hept-4-enyl-2 butyrate 
O
O
(E)- isomer shown  
0.79 
 
Class I 
A3: Intake below threshold 
4)  6)   
09.926 
 
Octan-3-yl formate  O
O  
0.24 
 
Class I 
A3: Intake below threshold 
4)  6)   
02.145 
 
2,6-Dimethylocta-1,5,7-trien-3-ol 
OH  
0.0085 
 
Class II 
A3: Intake below threshold 
4)  6)  a) Flavouring Group Evaluation 63, Revision 2 
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Table 10: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.07Rev4) 
FL-no  EU Register name  Structural formula  MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation 
remarks 
02.194 
 
Octa-1,5-dien-3-ol 
OH
 
0.061 
 
Class II 
A3: Intake below threshold 
4)  6)  a) 
02.211 
 
Undeca-1,5-dien-3-ol 
OH
 
0.061 
 
Class II 
A3: Intake below threshold 
4)  6)  a) 
07.072 
 
6-Methylheptan-3-one 
O
 
0.19 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.150 
 
Decan-2-one 
O
 
0.52 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.156 
 
2,6-Dimethyloct-6-en-3-one 
O
(E)- isomer shown  
0.0012 
 
Class II 
A3: Intake below threshold 
4)  7)   
07.157 
 
6,10-Dimethylundecan-2-one 
O
 
0.085 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.158 
 
Dodecan-2-one 
O
 
0.73 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.160 
 
Heptadecan-2-one 
O
 
0.12 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.162 
 
Hex-5-en-2-one 
O
 
0.049 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.181 
 
6-Methylheptan-2-one 
O
 
0.0012 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.185 
 
3-Methylpentan-2-one 
O
 
1.2 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.189 
 
Nonan-4-one 
O
 
0.52 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.198 
 
Pseudo-ionone 
O
 
0.12 
 
Class II 
A3: Intake below threshold 
4)  6)  a) 
07.199 
 
Tetradecan-2-one 
O
 
0.073 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.201 
 
Tridec-12-en-2-one 
O
 
0.024 
 
Class II 
A3: Intake below threshold 
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Table 10: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach)  (EFSA / FGE.07Rev4) 
FL-no  EU Register name  Structural formula  MSDI 1) 
(µg/capita/day) 
Class 2) 
Evaluation procedure path 
3) 
Outcome on the named 
compound 
[ 4) or 5)] 
Outcome on the 
material of 
commerce [6), 7), or 
8)] 
Evaluation 
remarks 
07.204 
 
3,3,6-Trimethylhepta-1,5-dien-4-
one 
O
 
0.012 
 
Class II 
A3: Intake below threshold 
4)  6)  a) 
07.205 
 
6,10,14-Trimethylpentadecan-2-
one 
O
 
0.0073 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.236 
 
5-Octen-2-one 
O
(Z)-isomer shown  
0.0097 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.262 
 
9-Decen-2-one 
O
 
73 
 
Class II 
A3: Intake below threshold 
4)  6)   
07.182 
 
5-Methylheptan-3-one 
O
 
0.32 
 
Class II 
B3: Intake below threshold, 
B4: Adequate NOAEL exists 
4)  6)  b) 
 
1)  EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2)  Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3)  Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4)  No safety concern based on intake calculated by the MSDI approach of the named compound. 
5)  Data must be available on the substance or closely related substances to perform a safety evaluation. 
6)  No safety concern at estimated level of intake of the material of commerce meeting the specification of Table 3 (based on intake calculated by the MSDI approach). 
7)  Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or information on stereoisomerism. 
8)  No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
a)  Evaluated in FGE.206, genotoxicity concern could be ruled out. 
b)  NOAEL for neurotoxicity: 82 mg/kg bw/day; Adequate Margin of Safety. 
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ABBREVIATIONS 
CAS    Chemical Abstract Service 
CEF    Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CHO    Chinese hamster ovary (cells) 
CoE    Council of Europe 
DNA    Deoxyribonucleic acid 
EFSA    The European Food Safety Authority 
EPA    United States Environmental Protection Agency  
EU    European Union 
FAO    Food and Agriculture Organization of the United Nations  
FEMA    Flavor and Extract Manufacturers Association 
FGE    Flavouring Group Evaluation  
FLAVIS (FL)  Flavour Information System (database) 
GLP    Good laboratory practise 
ID    Identity 
Ip    Intraperitoneal 
IR    Infrared spectroscopy 
JECFA   The Joint FAO/WHO Expert Committee on Food Additives 
MNBN   Micronucleated binucleate cells 
MSDI    Maximised Survey-derived Daily Intake 
mTAMDI  Modified Theoretical Added Maximum Daily Intake 
NCE    Normochromatic erythrocyte 
No    Number 
NOAEL  No observed adverse effect level 
NTP    National Toxicology Program 
OECD    Organisation for Economic Co-operation and Development 
PCE    Polychromatic erythrocyte 
RI    Replication Index 
SCE    Sister chromatic exchange Flavouring Group Evaluation 63, Revision 2 
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SCF    Scientific Committee on Food 
WHO    World Health Organisation 